Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.

scientific article published on January 2007

Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID17668556

P50authorHeidi E DrummerQ38323304
P2093author name stringIrene Boo
Hans-Jürgen Netter
Patricia T K Vietheer
P433issue4
P921main subjectHepatitis B virusQ6844
Hepatitis C virusQ708693
immunizationQ1415366
P304page(s)477-487
P577publication date2007-01-01
P1433published inAntiviral TherapyQ4775353
P1476titleImmunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies
P478volume12

Reverse relations

cites work (P2860)
Q27488724Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats
Q34389522HIV p24 as scaffold for presenting conformational HIV Env antigens
Q92881172Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Q37178225Immune responses during acute and chronic infection with hepatitis C virus
Q28604286Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus
Q35739112Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.
Q34933721Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus
Q34322342Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Q36281860Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
Q47100523Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.
Q37505405Prospects for prophylactic hepatitis C vaccines based on virus-like particles
Q33812653Subviral particle as vaccine and vaccine platform
Q41711102The Process of Wrapping Virus Revealed by a Force Tracing Technique and Simulations
Q45324462The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
Q45324534Virus like particles as a platform for cancer vaccine development.
Q39261291Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens

Search more.